Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Jose Carlos Florez, M.D.,Ph.D.

Co-Author

This page shows the publications co-authored by Jose Florez and Caroline Fox.
Connection Strength

1.727
  1. Common genetic variants differentially influence the transition from clinically defined states of fasting glucose metabolism. Diabetologia. 2012 Feb; 55(2):331-9.
    View in: PubMed
    Score: 0.124
  2. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes. 2011 Oct; 60(10):2624-34.
    View in: PubMed
    Score: 0.123
  3. TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study. Diabetologia. 2009 Apr; 52(4):614-20.
    View in: PubMed
    Score: 0.103
  4. Variants in the CNR1 and the FAAH genes and adiposity traits in the community. Obesity (Silver Spring). 2009 Apr; 17(4):755-60.
    View in: PubMed
    Score: 0.102
  5. Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring Study. Diabetes. 2009 Mar; 58(3):750-6.
    View in: PubMed
    Score: 0.102
  6. Haplotype structure of the ENPP1 Gene and Nominal Association of the K121Q missense single nucleotide polymorphism with glycemic traits in the Framingham Heart Study. Diabetes. 2008 Jul; 57(7):1971-7.
    View in: PubMed
    Score: 0.097
  7. A 100K genome-wide association scan for diabetes and related traits in the Framingham Heart Study: replication and integration with other genome-wide datasets. Diabetes. 2007 Dec; 56(12):3063-74.
    View in: PubMed
    Score: 0.093
  8. Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution. Nat Genet. 2019 03; 51(3):452-469.
    View in: PubMed
    Score: 0.051
  9. An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans. Diabetes. 2017 11; 66(11):2888-2902.
    View in: PubMed
    Score: 0.046
  10. Peripheral Blood Transcriptomic Signatures of Fasting Glucose and Insulin Concentrations. Diabetes. 2016 Dec; 65(12):3794-3804.
    View in: PubMed
    Score: 0.043
  11. Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat Genet. 2015 Dec; 47(12):1415-25.
    View in: PubMed
    Score: 0.041
  12. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet. 2014 Mar; 46(3):234-44.
    View in: PubMed
    Score: 0.036
  13. 2-Aminoadipic acid is a biomarker for diabetes risk. J Clin Invest. 2013 Oct; 123(10):4309-17.
    View in: PubMed
    Score: 0.035
  14. A combined epidemiologic and metabolomic approach improves CKD prediction. J Am Soc Nephrol. 2013 Jul; 24(8):1330-8.
    View in: PubMed
    Score: 0.035
  15. Lack of interaction of beta-cell-function-associated variants with hypertension on change in fasting glucose and diabetes risk: the Framingham Offspring Study. J Hypertens. 2013 May; 31(5):1001-9.
    View in: PubMed
    Score: 0.034
  16. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012 Sep; 44(9):981-90.
    View in: PubMed
    Score: 0.033
  17. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet. 2012 May 13; 44(6):659-69.
    View in: PubMed
    Score: 0.032
  18. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet. 2012; 8(3):e1002607.
    View in: PubMed
    Score: 0.032
  19. No interactions between previously associated 2-hour glucose gene variants and physical activity or BMI on 2-hour glucose levels. Diabetes. 2012 May; 61(5):1291-6.
    View in: PubMed
    Score: 0.032
  20. A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One. 2012; 7(1):e29202.
    View in: PubMed
    Score: 0.031
  21. Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies. J Clin Endocrinol Metab. 2011 Oct; 96(10):3242-9.
    View in: PubMed
    Score: 0.031
  22. Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: a 14-cohort meta-analysis. Diabetes. 2011 Sep; 60(9):2407-16.
    View in: PubMed
    Score: 0.031
  23. Variants at the endocannabinoid receptor CB1 gene (CNR1) and insulin sensitivity, type 2 diabetes, and coronary heart disease. Obesity (Silver Spring). 2011 Oct; 19(10):2031-7.
    View in: PubMed
    Score: 0.030
  24. Metabolite profiles and the risk of developing diabetes. Nat Med. 2011 Apr; 17(4):448-53.
    View in: PubMed
    Score: 0.030
  25. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest. 2011 Apr; 121(4):1402-11.
    View in: PubMed
    Score: 0.030
  26. CUBN is a gene locus for albuminuria. J Am Soc Nephrol. 2011 Mar; 22(3):555-70.
    View in: PubMed
    Score: 0.030
  27. Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care. 2011 Jan; 34(1):121-5.
    View in: PubMed
    Score: 0.029
  28. Common variants at 10 genomic loci influence hemoglobin A1(C) levels via glycemic and nonglycemic pathways. Diabetes. 2010 Dec; 59(12):3229-39.
    View in: PubMed
    Score: 0.029
  29. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010 Jul; 42(7):579-89.
    View in: PubMed
    Score: 0.028
  30. Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum Mol Genet. 2010 Jul 01; 19(13):2706-15.
    View in: PubMed
    Score: 0.028
  31. Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes. 2010 May; 59(5):1266-75.
    View in: PubMed
    Score: 0.028
  32. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet. 2010 Feb; 42(2):142-8.
    View in: PubMed
    Score: 0.027
  33. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010 Feb; 42(2):105-16.
    View in: PubMed
    Score: 0.027
  34. Variants in MTNR1B influence fasting glucose levels. Nat Genet. 2009 Jan; 41(1):77-81.
    View in: PubMed
    Score: 0.025
  35. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med. 2008 Nov 20; 359(21):2208-19.
    View in: PubMed
    Score: 0.025
  36. Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study. Diabetes. 2008 Dec; 57(12):3353-9.
    View in: PubMed
    Score: 0.025
  37. TCF7L2 variants associate with CKD progression and renal function in population-based cohorts. J Am Soc Nephrol. 2008 Oct; 19(10):1989-99.
    View in: PubMed
    Score: 0.025
  38. Genome-wide association with diabetes-related traits in the Framingham Heart Study. BMC Med Genet. 2007 Sep 19; 8 Suppl 1:S16.
    View in: PubMed
    Score: 0.023
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.